Patients’ preferences for treatment with the new direct acting antiviral therapies for chronic hepatitis C virus infection

OBJECTIVES: The efficacy of new direct-acting antivirals (DAAs) in treating hepatitis C infection can depend on treatment adherence, which may be influenced by the patient’s current lack of awareness of the disease. This study set out to understand the treatment naïve chronic hepatitis C patients’ p...

Descripción completa

Detalles Bibliográficos
Autores principales: Simón, MA, Rojo, O, Ryan, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Sanidad Penitenciaria 2021
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592264/
https://www.ncbi.nlm.nih.gov/pubmed/34279534
http://dx.doi.org/10.18176/resp.00033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592264/
https://www.ncbi.nlm.nih.gov/pubmed/34279534
http://dx.doi.org/10.18176/resp.00033

Ejemplares similares